HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	784,563	1,219,355	1,165,599	1,077,864	1,188,951	1,280,316
Market Cap Growth	4.61%	4.61%	8.14%	-9.34%	-7.14%	-1.96%
Enterprise Value	829,264	1,270,943	1,260,366	1,030,778	1,020,209	1,153,412
Last Close Price	6440.00	10010.00	11155.39	10327.26	11533.40	12598.74
PE Ratio	119.26	198.66	-	-	-	-
PS Ratio	7.67	11.93	11.90	10.82	22.23	13.95
PB Ratio	1.97	3.06	5.04	4.57	4.82	4.45
P/TBV Ratio	2.22	3.45	6.66	7.52	6.48	6.10
P/OCF Ratio	-	-	-	-	-	636.96
EV/Sales Ratio	8.11	12.43	12.86	10.35	19.07	12.57
EV/FCF Ratio	-13.98	-	-	-	-	-
Debt / Equity Ratio	0.31	0.31	0.72	0.63	0.02	0.04
Asset Turnover	0.21	0.21	0.24	0.29	0.18	0.25
Inventory Turnover	18.44	18.44	12.26	16.27	30.72	19.42
Quick Ratio	1.86	1.86	0.68	5.50	11.28	9.85
Current Ratio	2.01	2.01	0.73	6.00	11.59	10.15
Return on Equity (ROE)	1.97%	1.97%	-2.53%	-22.52%	-18.45%	-17.95%
Return on Assets (ROA)	-2.73%	-2.73%	-3.82%	-3.65%	-3.83%	-1.37%
Return on Capital (ROIC)	-2.86%	-2.86%	-4.08%	-3.93%	-4.16%	-1.55%
Earnings Yield	0.78%	0.50%	-0.51%	-5.04%	-4.13%	-4.36%
FCF Yield	-7.56%	-4.86%	-2.63%	-3.75%	-1.39%	-0.50%
Buyback Yield / Dilution	-10.73%	-10.73%	-0.80%	-1.64%	-0.34%	-6.39%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.